The nurse is planning the care of a patient with Parkinson's disease. The nurse should be aware that treatment will focus on what pathophysiology?

Choice A reason: Acetylcholine levels in Parkinson's disease are actually relatively excessive in comparison to dopamine. The symptoms of the disease arise from an imbalance between these two neurotransmitters; therefore, treatment often involves anticholinergic medications to lower acetylcholine activity, rather than preventing its degradation. Choice B reason: Parkinson's disease is characterized by the progressive degeneration of dopaminergic neurons in the substantia nigra of the basal ganglia. This leads to a severe deficiency of dopamine, the neurotransmitter responsible for smooth, coordinated motor movement. Pharmaceutical treatments, such as levodopa, focus on restoring these dopamine levels or stimulating dopamine receptors. Choice C reason: While epinephrine is a catecholamine involved in the sympathetic nervous system's stress response, its synthesis is not the primary pathological target in Parkinson's disease. The motor symptoms of tremors, rigidity, and bradykinesia are specifically linked to the loss of nigrostriatal dopaminergic pathways. Choice D reason: Serotonin reuptake is the primary focus of treatments for clinical depression and anxiety disorders. Although Parkinson's patients may experience depression due to low serotonin levels as a secondary effect of neurodegeneration, the core motor pathophysiology and primary treatment focus remain centered on the dopamine deficit.